Health and Fitness Health and Fitness
Fri, May 11, 2012
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012

Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. sche-bank-37th-annual-healthcare-conference.html
Published in Health and Fitness on Thursday, May 3rd 2012 at 15:46 GMT by Market Wire   Print publication without navigation


Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference -- THOUSAND OAKS, Calif., May 3, 2012 /PRNewswire/ --

Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference

[ ]

THOUSAND OAKS, Calif., May 3, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) will present at the Deutsche Bank 37th Annual  Healthcare Conference on Tuesday, May 8, 2012, at the InterContinental Hotel, Boston, Mass., beginning at 9:20 a.m. Eastern Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, [ www.amgen.com ], under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit [ www.amgen.com ]. Follow us on [ www.twitter.com/amgen ].

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Eric Hyllengren, 805-447-1060 (investors)

(Logo:  [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])

SOURCE Amgen

[ Back to top ]

RELATED LINKS
[ http://www.amgen.com ]


Publication Contributing Sources